- Exchange: Tokyo
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Takeda Pharmaceutical Co Ltd
+ Add to Watchlist4502:JP
4,945 JPY 5 0.10%
Share
As of 02:00:00 ET on 05/21/2013.
More on 4502
News for Takeda Pharmaceutical Co Ltd (4502)
-
COMPANY NEWS
-
PRESS RELEASES
-
INDUSTRY NEWS
- Lundbeck-Takeda Drug Fights Depression Better at Higher Dose
- Takeda Falls Most in 4 Years After Missing Forecast: Tokyo Mover
- Arena Withdrawing Obesity Drug Regulatory Application in Europe
- Global Piracy, SAP, Takeda, GM: Intellectual Property
- Takeda Gets $6.5 Million Diabetes-Drug Verdict Thrown Out
- Sucampo Wins Approval for Expanded Use of Amitiza in U.S.
- E-Books, Sony Music, Glaxo, IBM: Intellectual Property
- Glaxo Sent U.K. Charge Sheet for Paying to Delay Seroxat Copies
- Takeda Denies Actos Bladder-Cancer Link at First Trial
- Mantel, Smith on Women’s Prize for Fiction Shortlist
- Takeda’s Actos Diabetes Drug Tied to Cancer, Jury Is Told
- Sidley, Patton Boggs, Bird, Perkins Coie: Business of Law
- AstraZeneca CEO Chases Multiple Strands in RNA Drug Quest
- Norovirus Spurs 1 Million Doctor Visits by U.S. Children
- Arena Joins Vivus Finding Obesity Drugs Fizzle on Costs
- Ferumoxytol Treatment Produced Significant Hemoglobin Increases in Adult Iron Deficiency Anemia Patients With Gastrointestinal Published 3 hours ago
- Takeda And Lundbeck Present Results From Pivotal Phase 3 Clinical Trials With Vortioxetine, An Investigational Compound For Published May 18, 2013
- Intra-Cellular Therapies Appoints Professor Sir Michael Rawlins to its Board of Directors Published May 14, 2013
- Takeda Pharmaceutical Company Limited Announces Financial Results for the Fiscal Year Ended March 31, 2013 and Forecasts for the Published May 09, 2013
- Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013 Published May 08, 2013
- Takeda to Acquire Inviragen, Inc. Published May 07, 2013
- Furiex Reports First Quarter 2013 Financial Results Published May 07, 2013
- Ferumoxytol Results in Significant Hemoglobin Increases in Adult Iron Deficiency Anemia Patients With Abnormal Uterine Bleeding Published May 06, 2013
- Judge Nullifies Verdict in Diabetes Drug Case Published May 01, 2013
- Huge Plaintiffs' Victory Seen In First Actos® Trial Published Apr 29, 2013
- Heptares Achieves All Research Milestones and Receives Milestone Payment From GPCR Drug Discovery Agreement With Takeda Published Apr 29, 2013
- Glancy Binkow & Goldberg Encourages Investors to Inquire About a Lead Plaintiff Position in the Class Action Lawsuit Against Published Apr 28, 2013
- Takeda Responds to Verdict in Diabetes Drug Case Published Apr 26, 2013
- Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline in the Class Action Lawsuit against Affymax, Inc. Published Apr 23, 2013
- AMAG Announces First Quarter 2013 Financial Results Published Apr 23, 2013
- German Shares Little Changed; Banks Fall, Chemicals Gain Updated 16 minutes ago
- Medtronic’s Heart Rhythm Devices Show Signs of Growth Updated 1 hour ago
- Sanofi, Roll Global, Heineken, WWE: Intellectual Property Updated 4 hours ago
- China Stocks Rise for Fifth Day, Longest Streak in Three Months
- Novartis Sees MorphoSys Muscle-Atrophy Drug as Exciting
- Kasowitz Benson, Eversheds, Latham, Davis:Business of Law
- ‘Love Hormone’ Promises Safer Births After Pfizer Flop
- Teva Bets on Reformulating Old Drugs as Investors Say ‘Show Me’
- Actavis to Buy Warner Chilcott in Women’s Health Effort
- Royalty Pharma Raises Elan Bid to $12.50 a Share in Cash
- Vitamins That Cost Pennies a Day Seen Delaying Dementia
- XenoPort Sinks as Spasticity Drug For MS Fails in Trial
- Merck Insomnia Drug Safer at Lower Dose, FDA Staff Says
- Elan Makes Two Acquisitions for $380 Million
- China’s Stocks Rise to Seven-Week High as Trading Volumes Surge
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Advertisement
Rate this Page